RARA CRAFT DATABASE for FDA Medical Devices
510(k)K162851

FDA DEVICE FACTS

eLyx-PRO

Intelligent Sensory Concept SA

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJanuary 24, 2017PRODUCT CODEGEX

Indications for use

Elyx PRO is intended to emit energy in the blue & red region of the spectrum for use in dermatology for treatment of mild to moderate forms of acne. Elyx PRO is intended to emit energy in the red & near-infrared region of the spec trum for use in dermatology for treatment of periorbital wrinkles. Elyx PRO is intended to emit energy in the red & near-infrared region of the spectrum for temporary relief of minor muscle & joint pain, arthritis and muscle spasm, and relieving stiffness ELyx-PRO targeted population is adult man & woman (except pregnant woman), and it is intended to be used on both face & body (contraindication on broken or damaged skin nor mucosal). The device is indicate to be used between 1 and 10 cm, per session of 2 to 15 minutes twice or thrice a week (depending the protocol).

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 31, 2026